Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly.
| Website | https://kolibrilab.com/ |
| Employees | 11 (7 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology |
| Keywords | Cell Engineering, Cell Culture, Cellular Engineering, Bioprocessing, Biotechnology, Biotechnology Solutions |
| Competitors | University of Nottingham, Benchling, Evernote, Chemaxon, Enthought, Dataquest.io, LabArchives, LLC, Labstep +44 more (view full list) |
Looking for a particular Kolibri employee's phone or email?
Gabriel Dumy is the CEO and Founder of Kolibri.
7 people are employed at Kolibri.
Kolibri is based in Paris, Île-de-France.